Integrating Next-Generation Sequencing Disease Evaluation and PCR Based CAR-T cell Tracking to Guide Decision Making in a Real-World Cohort of Pediatric B-cell ALL Patients.
Puntos clave
Integration of next-generation sequencing and PCR significantly enhances decision-making in B-cell ALL treatment.
The approach improves tracking of CAR-T cells in real-world pediatric populations, ensuring targeted therapies are effective.
Observational study leverages sequencing data alongside CAR-T therapy to optimize treatment paths for children with ALL.
Findings support more personalized care strategies in pediatric oncology, addressing critical gaps in traditional monitoring.
Me gusta
Guardar
Compartir
Me gusta
Guardar
Compartir
Integrating Next-Generation Sequencing Disease Evaluation and PCR Based CAR-T cell Tracking to Guide Decision Making in a Real-World Cohort of Pediatric B-cell ALL Patients. | Synapse